Clinical Trial Update: Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a quadruple combination of gemcitabine, cisplatin, lenvatinib, and adebrelimab for advanced, unresectable intrahepatic chola…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING